Electrocardiographic Evaluation in Patients Receiving Lamotrigine Monotherapy/Duotherapy
Objective:Despite its widespread use and safety data, the cardiac safety of lamotrigine was brought into question in October 2020 when the U.S. Food and Drug Administration issued a safety warning about its cardiac side effects. Here, we investigated whether there are differences in electrocardiogra...
Main Authors: | Merve Hazal Ser, Bengi Gül Türk, Özgür Selim Ser, Seher Naz Yeni |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2023-12-01
|
Series: | Archives of Epilepsy |
Subjects: | |
Online Access: |
http://archepilepsy.org/archives/archive-detail/article-preview/electrocardiographic-evaluation-in-patients-receiv/63560
|
Similar Items
-
Action Tremor Associated with Lamotrigine Monotherapy
by: Ji-Hye Yang, et al.
Published: (2010-05-01) -
Evaluation of electrocardiographic parameters in amputee football players
by: Ahmet Kurtoğlu, et al.
Published: (2023-07-01) -
Electrocardiographic changes associated with hyperkalaemia in domestic cats
by: S. P. Bakshi, et al.
Published: (2023-03-01) -
Use of Lamotrigine in the pharmacological management of a lady with longstanding history of Trichotillomania
by: J.H. Tan, et al.
Published: (2022-06-01) -
A Rare Side Effect of Lamotrigine: Hallucination
by: Hatice Ferhan KÖMÜRCÜ
Published: (2021-03-01)